Pakistan
· Delayed Price · Currency is PKR ABOT Statistics
Total Valuation
Abbott Laboratories (Pakistan) has a market cap or net worth of PKR 77.28 billion. The enterprise value is 73.83 billion.
| Market Cap | 77.28B |
| Enterprise Value | 73.83B |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Abbott Laboratories (Pakistan) has 97.90 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Shares Outstanding | 97.90M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 9.37% |
| Float | 20.69M |
Valuation Ratios
The trailing PE ratio is 24.15.
| PE Ratio | 24.15 |
| Forward PE | n/a |
| PS Ratio | 1.28 |
| PB Ratio | 3.76 |
| P/FCF Ratio | 52.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.63, with an EV/FCF ratio of 50.26.
| EV / Earnings | 23.06 |
| EV / Sales | 1.22 |
| EV / EBITDA | 12.63 |
| EV / EBIT | 17.80 |
| EV / FCF | 50.26 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.65 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.05 |
| Interest Coverage | 232.47 |
Financial Efficiency
Return on equity (ROE) is 17.31% and return on invested capital (ROIC) is 13.93%.
| Return on Equity (ROE) | 17.31% |
| Return on Assets (ROA) | 7.19% |
| Return on Capital (ROIC) | 13.93% |
| Revenue Per Employee | 42.26M |
| Profits Per Employee | 2.24M |
| Employee Count | 1,430 |
| Asset Turnover | 1.68 |
| Inventory Turnover | 3.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +126.19% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +126.19% |
| 50-Day Moving Average | 754.68 |
| 200-Day Moving Average | 608.67 |
| Relative Strength Index (RSI) | 57.55 |
| Average Volume (20 Days) | 127,282 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Abbott Laboratories (Pakistan) had revenue of PKR 60.43 billion and earned 3.20 billion in profits. Earnings per share was 32.69.
| Revenue | 60.43B |
| Gross Profit | 14.29B |
| Operating Income | 4.15B |
| Pretax Income | 5.13B |
| Net Income | 3.20B |
| EBITDA | 5.76B |
| EBIT | 4.15B |
| Earnings Per Share (EPS) | 32.69 |
Balance Sheet
The company has 3.53 billion in cash and 76.01 million in debt, giving a net cash position of 3.45 billion or 35.27 per share.
| Cash & Cash Equivalents | 3.53B |
| Total Debt | 76.01M |
| Net Cash | 3.45B |
| Net Cash Per Share | 35.27 |
| Equity (Book Value) | 20.54B |
| Book Value Per Share | 209.82 |
| Working Capital | 8.70B |
Cash Flow
In the last 12 months, operating cash flow was 4.11 billion and capital expenditures -2.64 billion, giving a free cash flow of 1.47 billion.
| Operating Cash Flow | 4.11B |
| Capital Expenditures | -2.64B |
| Free Cash Flow | 1.47B |
| FCF Per Share | 15.00 |
Margins
Gross margin is 23.65%, with operating and profit margins of 6.87% and 5.30%.
| Gross Margin | 23.65% |
| Operating Margin | 6.87% |
| Pretax Margin | 8.50% |
| Profit Margin | 5.30% |
| EBITDA Margin | 9.52% |
| EBIT Margin | 6.87% |
| FCF Margin | 2.43% |
Dividends & Yields
Abbott Laboratories (Pakistan) does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 75.06% |
| Buyback Yield | -0.07% |
| Shareholder Yield | -0.07% |
| Earnings Yield | 4.14% |
| FCF Yield | 1.90% |
Stock Splits
The last stock split was on August 9, 2006. It was a forward split with a ratio of 1.20482.
| Last Split Date | Aug 9, 2006 |
| Split Type | Forward |
| Split Ratio | 1.20482 |
Scores
Abbott Laboratories (Pakistan) has an Altman Z-Score of 4.86.
| Altman Z-Score | 4.86 |
| Piotroski F-Score | n/a |